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Abstract 
Damage to avascular tissue often requires medical attention due to its inability to regenerate 
healthy tissue. Tissue engineering has the potential to repair this damage by growing thick tissue 
in vitro with properties and geometry similar to the innate tissue by seeding three dimensional 
(3D) scaffolds in hydrogels. Scaffold designs must increase internal surface area and void 
fraction to provide nutrients to the center of the scaffold to ensure viability and sustainable 
growth.  
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1 – Introduction 
Avascular cartilage, such as that found within the knee meniscus, does not have the 
regenerative capabilities of other tissues. This is largely due to low nutrient flow caused by the 
lack of blood vessels running throughout the tissue. Currently, any tears or wounds that occur in 
avascular cartilage cannot be healed and must be treated by either removing damaged sections of 
the tissue or complete removal of the cartilage, as in a meniscectomy. Alternative treatment for 
avascular cartilage tears, such as tissue engineering, could provide a solution to this problem. 
However, tissue engineering thick, avascular tissue ex vivo leads to the some of the same issues 
as in vivo healing. A current challenge with growing thick tissue is mitigating with the necrosis 
of cells within the center of the tissue when it is grown using three dimensional culture. Cell 
necrosis occurs from a lack of proper nutrient penetration within the tissue culture and is usually 
seen within tissue culture greater than 1mm. This project aimed to improve the clinical treatment 
for improved avascular cartilage treatment via the creation of a 3-dimensional (3D) 
biodegradable scaffold that could prevent cell necrosis in thick tissue culture. 
The scaffold was modeled in CAD software and then printed using a desktop 3D printer. 
The scaffold was designed to fulfill the cells proliferatory needs in order for the tissue to 
successfully grow. The material Poly-Lactic Acid (PLA) was used as it is compatible with 3D 
printing, biocompatible, and biodegradable, which were essential material properties for this 
project.  
Cells from the ATDC5 mouse cell line were cultured to produce chondrocytes, which 
were then seeded onto the printed scaffold using a collagen hydrogel. Cell proliferation was 
scaled to coincide with degradation of the scaffold so that the chondrocytes form avascular 
cartilage as the scaffold degrades. Once cultured in the lab, the viability of the tissue engineered 
cartilage will be validated through histological testing. 
2 – Literature Review 
This report describes the methodology and results of growing cartilaginous thick tissue 
using a 3D printed biodegradable scaffold. Pertinent research regarding 3D printing, tissue 
engineering, and methods of histological analysis are summarized in the following literary 
review.  
Project Number DGF – 111C 
2.1 – 3D Printing 
2.1.1 – Printer History 
A growing frontier in the field of modern tissue engineering has been the increasing 
usage of three dimensional (3D) printers for organ printing and scaffold creation for tissue 
growth. These printers allow for the construction of live tissue in what can be considered a 
relatively short period of time when compared to other methods used for tissue growth. These 3D 
printed tissues can be custom made for each patient and made from the patients’ own cells. Once 
printed the tissue or organs can then be placed inside the patient to repair or replace damaged 
tissue (Melchels 2005).  
The inception of 3D printing can be traced back to the late 1940’s, right after World War 
II, when John Parsons invented numerical control for manufacturing machines. What this means 
is that any machine used in the manufacturing process has every parameter and variable 
controlled by a computer, where before these processes had to be done by hand (Bradshaw et al. 
2010). This idea of allowing a computer to automate the manufacturing process was a turning 
point in the manufacturing industry as it allowed a process once done by humans to be 
completely automated. It wasn’t until the 1970’s though that the combination of a joke and 
numerical controls would lead to the birth of the 3D printing industry. In 1974 David Jones 
would write a small joke in his column in New Scientist that lasers could be shone into a liquid 
plastic monomer and cause the monomer to solidify. Jones expounded upon his joke by 
proposing that the wavelengths could be adjusted so that solidification of the polymer could only 
be achieved when two separate beams intersected (Bradshaw et al. 2010). This entire process 
would be computer controlled to ensure proper deflection of the lasers. 
What initially started off as a tongue-in-cheek joke was soon made reality when Wyn 
Kelly Swainson was granted a patent for a similar idea in 1977. Swainson’s patent used a laser to 
cause covalent crosslinking of a liquid monomer at its surface while the object being created 
rested on a tray that was lowered as more material was added to the object. This was the start of 
the 3D printing industry and the industry rapidly grew in the following years. One reason for 3D 
printings rapid growth was thanks to the lack of need to use tool path calculations to cut away 
material. Since material is being added, layer by layer, to a constant flat surface by a laser it is 
much easier to write a program to control the process of manufacturing (Bradshaw et al. 2010). 
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While 3D printing is slightly less accurate than forming an object by removing material it allows 
for the creation of complex and intricate shapes.  
2.1.2 – Organ Printing/Bioprinting 
One area of research in 3D printing includes the direct printing of tissue and organs 
through the use of cell seeded hydrogels. This process is called organ printing or bioprinting and 
is the process by which tissue and organs are created through the deposition of cells, layer by 
layer, in a hydrogel onto a sterile surface. This process is aided by computer aided design (CAD) 
software to accurately layer the hydrogel into the proper form where a model is created using 
CAD and that model is then uploaded to the 3D printer. The printer will then read the model file 
and begin to create the tissue/organ model layer by layer (Mirinov 2003). Cells within the 
hydrogel will begin to mature and vascularize into living tissue. Different types of tissue and 
organ printing include jet-based cell printers, biplotters, and cell dispensors.  
Currently organ printing is a three step process of pre-processing, processing, and post-
processing of organs (Mirinov 2003). In pre-processing a CAD model of the tissue to be printed 
is created and this model acts like a blueprint of the tissue. It must accurately replicate the model 
to ensure that the printed tissue replicated the biomechanical properties of the in-vivo tissue. In 
the processing phase the CAD model is used to actually print the tissue using a 3D printer. This 
is usually done through the process of layering hydrogels into the 3D model. Finally, post-
processing is the process in which the cell seeded hydrogel is cultivated until the cells have 
differentiated into the proper tissue.  
Some advantages that current 3D bioprinting methods have when compared to other 
printing methods include precise spatial placement of cells during printing, precise placement of 
various biomaterials, and multiple placement of cell types such as smooth muscle and endothelial 
cells (Ozbolat et al. 2013). This method of 3D printing can also be classified into 3 categories 
which are as follow; laser based printing, inkjet based printing, and extrusion based printing.  
2.1.2.1 – Laser Printing 
Laser printing is the process by which trypsinized and centrifuged cells are suspended in 
a hydrogel with an adequately determined viscosity (Chichkov et al. 2013). This hydrogel is then 
placed between two glass slides with the upper slide called the donor slide and bottom slide 
called the collector slide. The donor slide is covered with a radiation absorbing layer material to 
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absorb the laser and a thin layer of material containing the cells and then placed a few hundred 
micrometers above the collector slide. A laser pulse is then sent through the slides which is 
absorbed by the donor slide and creates a shockwave that propels the cells onto the collector 
slide (Ozvolat 2013). This process is repeated to create the 3D object. 
2.1.2.2 – Inkjet Printing 
Inkjet printing is a 3D printing technique in which living cells are formed into droplets 
within the printer which then takes a digital image of what is to be printed and reproduced the 
digital image on a substrate with the cell ink droplets (Boland et al., 2006). This method of 
printing allows for very small scale printing of items such as complex integrated circuits and 
biosensors. Inkjet printers can also be modified to allow for additional print heads that can 
deposit multiple cell types, which would allow for heterocellular tissue (Ozbolat et al. 2013). 
Inkjet catridge design has also shown to allow for precise spatial delivery of multiple cell types 
in situ (Binder 2011).      
2.1.2.3 – Extrusion-Based Deposition 
Extrusion-based printing is the process by which cylindrical struts, composed of certain 
biomaterials and a cell solution, are continuously extruded onto a base. This base is coated with 
chemical crosslinkers that cause the cells to begin crosslinking in the biomaterial upon extrusion 
upon the base (Ozbolat et al. 2013). Extrusion-based printing shows potential for direct organ 
printing thanks to its cell patterning capability.  
2.1.3 – 3D Scaffold Printing 
A second method of 3D printing for tissue and organs is the creation of biodegradable 
scaffolds onto which cells are seeded and allowed to grow into the tissue and organs. Similar to 
organ printing the first step in scaffold creation is through the modeling of living tissue with the 
use of CAD. A 3D model of the tissue or organ is created to accurately replicate either the 
complete tissue or the section of damaged tissue that must be repaired. Once the model is 
completed a porous scaffold can be generated that will be printed layer by layer using a 3D 
printer. This scaffold must meet many requirements such as proper replication of biomechanical 
properties, proper nutrient delivery to the seeded cells, an optimal degradation rate of the 
scaffold material (Pfister 2003) and optimal ratio of scaffold material to pores. If the scaffold 
cannot properly replicate the biomechanical properties of the tissue than the cells may not 
accurately differentiate into the tissue with the proper biomechanical properties and the scaffold 
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itself could collapse and destroy the cells. Nutrient delivery is also important to ensure the 
viability of the tissue being grown for implant, the scaffold must ensure that the cells within the 
center do not die. Finally if the scaffold cannot degrade at a rate matching the growth and 
proliferation of the cells then the cells will cease proliferation and begin differentiation.  
2.2 – Cartilage/Tissue Engineering 
2.2.1 – Bioreactors 
Bioreactors are devices engineered to promote biological growth and activity. There are 
many advantages of using a bioreactor to culture tissue as opposed to traditional static methods. 
These systems replicate physiological conditions and allow for the delivery of mechanical 
stimuli. Alterations made to these parameters can result in cellular differentiation and changes to 
the extracellular matrix (ECM) they secrete. Controlling pH, media flow, and mechanical stimuli 
that tissue engineered cartilage experience in vivo can be used to produce a tissue with a 
homogenous distribution of viable cells along with ECM that provides similar mechanical 
properties to natural cartilage (Athanisiou 2003). For instance metabolism of ECM components 
is most efficient in chondrocytes cultured in pH ranging from 6.9 to 7.2 (Pazzano 1999).    
Flow of culture media is also a common function for bioreactors used in tissue 
engineering applications. Exposing tissue engineered (TE) cartilage to fluid movement with a 
velocity of 1 µm/s, similar to movement of fluid within joints, while culturing tissue results in 
more ECM being secreted by the cells along with perfusivity of the media throughout scaffolds. 
Media flow and perfusion throughout a seeded scaffold is important when a homogenous 
distribution of living cells and matrix is desired. Increased mass transfer of nutrients and waste 
products between the media and cells throughout the tissue engineered construct will result tissue 
that is similar to natural tissue when compared histologically (Pazzano 1999).    
Collagen types I and II as well as glycosaminoglycan (GAG) are components of the ECM 
of the meniscus, and the distribution, concentration, and orientation of them gives the meniscus 
its unique mechanical properties. Bioreactors that include a computer controlled piston can 
produce hydrostatic pressure that is evenly distributed upon cells seeded in a scaffold. 
Chondrocytes experience forces of 7 – 10 MPa in joints during normal day to day activities. 
Tailoring the magnitude of mechanical stimuli to the cells to what they would experience in the 
body leads to a tissue engineered product more congruent with the cartilage it would potentially 
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replace in the body, making this a promising technique when culturing tissue to be used as a 
transplant. Tissue engineered cartilage grown within bioreactors capable of cyclical mechanical 
stimuli within this physiological range have been shown to increase final amounts of collagen 
types I and II and GAG as well as mRNA used to produce them. Quantitative PCR used on 
samples of tissue engineered cartilage cultured within this type of bioreactor displayed a 9 fold 
increase in collagen coding mRNA and a 21 fold increase in GAG containing proteoglycan 
coding mRNA. (Athanisiou 2003).  
2.2.2 – Thick Tissue Culture 
The generation of thick tissue structures is a challenge faced in the field of tissue 
engineering. Cells towards the surface of the scaffold are well supplied with nutrients from the 
media and the waste they produce is removed efficiently, but necrosis is often observed in the 
center where diffusion limits this mass transfer. One attempt to remedy this problem is through 
the incorporation of vascularization systems to scaffold design. Just as the body’s vascular 
system overcomes the limits posed by diffusion through tissues, channels and systems of 
capillaries can be designed to mimic this and increase mass transfer in thick tissue culture (Ko et 
al. 2007). 
2.3 – Case Study: The Meniscus 
2.3.1 - Relevance  
The meniscus is one example of a thick, avascular, cartilaginous tissue that would benefit 
from this kind of tissue engineering method. The lateral and medial menisci are the cartilaginous 
crescent-shaped wedges which provide lubricant and shock absorption to the knee joint. The 
knee menisci are often torn in sports-related injuries and degenerate in people aged 65 and older. 
Meniscal avascularity in fully developed tissue makes it difficult for the meniscus to heal when 
injured. The meniscus’ composition changes as the body matures. A fetal meniscus is highly 
vascularized to promote growth but this vascularization decreases as the body matures and the 
knee joint bears weight (i.e. from crawling and walking.) The meniscus is left with 20% 
vascularization, most of which lies in the periphery of the cartilage, as seen in the image below 
in the “Red Zone” of the cartilage, while the remaining “White Zones” of the meniscus are 
avascular. Damage to the avascular “White Zone” of the menisci often require surgical 
reparations since the tissue cannot regenerate. The frequency and treatment of meniscal tears are 
discussed in the following section. 
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FIGURE 1: DIAGRAM OF MENISCUS AND COMMON TEARS (HEALTHWARE INC., 2012) 
2.3.2 – Meniscal Tears and Treatment 
Meniscal tears are the most common knee injuries and often coincide with other knee 
injuries, such as ACL tears. Once the knee joint has been afflicted with an injury, it is more 
likely to be reinjured.  There are many mechanisms of injury that can cause the meniscus to tear, 
including acute twisting and impact at the knee joint, getting up from a squatting position and 
loading the knee from a fixed position (LaBella, M., 2007.) In individuals under 20 years old, 
every 11 of 12 meniscal tears are sports induced. As the focus group gets older, less meniscal 
injuries are attributed to sports injuries and more degenerative tears are present.  
TABLE 1: PERCENTAGES OF SPORTS RELATED IJURIES WITH RESPECT TO AGE (LABELLA, M., 2007) 
Age 
Range 
% of Sports 
Related 
Injuries 
<20 91.7 
20-29 64.5 
30-39 30.6 
40-49 19.6 
50-59 14.3 
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While not all meniscal tears are symptomatic, common symptoms are swelling, pain in the joint, 
pain when squatting or kneeling, locking, and loss of extension of the knee joint. 
Depending on the severity of the symptoms and MRI of a meniscal tear depend on the 
route to recovery one takes. Menisci that must be treated undergo rehabilitation via physical 
therapy and/or surgery including either the repair or removal of the cartilage. Surgery is 
generally chosen as the recovery method when the tear; is in the avascular zone, therefore 
lacking the ability to heal itself properly, is longer than 5-8 millimeters in length, or is so painful 
daily function is limited. Annually, there are approximately 500,000 - 1,000,000 meniscal 
operations performed in the United States, grossing to $4 billion. Physical therapy is needed after 
surgery as well as when it is the primary recovery mechanism. A patient generally undergoes two 
phases of physical therapy, the first where the therapist tries to reduce swelling and the second 
where the therapist focuses on strengthening and stabilizing the joint. A meniscal injury that 
requires medical attention is both slow to heal and expensive to treat.  
2.3.3 – Biomechanics of Meniscus 
The biomechanics of the menisci is essential to the knees functionality as discussed 
earlier. The menisci are kinematic bodies; they move as forces are exerted on them from the knee 
joint. The flexion and extension of the knee joint ranges for the different activities humans do, as 
shown in the table below.   
 
TABLE 2: RANGE OF TIBIOFEMORAL JOINT MOTION IN THE SAGITTAL PLANE DURING COMMON ACTIVITIES (NORDIN, M. 
ET AL. 2001) 
Activities Range of motion from Knee 
extension to Flexion 
(Degrees) 
Walking 0-67 
Climbing Stairs 0-83 
Descending Stairs 0-90 
Sitting Down 0-93 
Tying a Shoe 0-106 
Lifting an Object 0-117 
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The lateral meniscus moves 3-5 times more than the medial meniscus in flexion (Brantigan, 
1941) (DePalma, 1957.) Figure 2 shows the mean movement, of the menisci in millimeters. 
Areas where the meniscal movement is inhibited and there is little displacement, such as the 
posterior horn of the medial meniscus, are especially prone to impact injury because they are not 
compliant like the rest of the tissue (Fox, A. et al., 2011) The stresses exerted on the meniscus 
are largely compressive due to the load exerted by the body’s weight. The stresses on the 
meniscus are circumferential “hoop” stresses, which are then converted to axial forces and 
tensile stresses along the circumferential collagen fibers of the meniscus (Fox, A. et al., 2011) 
The meniscus also absorbs shock; a knee joint with a meniscus absorbs 20% more shock than a 
knee joint with a menisectomy (Fox, A. et al., 2011) The menisci play an important role in 
stabilizing the knee joint; they are compressed by rounded femoral condyles, splaying out to 
create a flatter, more stable surface. The micro-canals of the meniscus, which are located near the 
periphery of the cartilage, act to transport nutrients to the joint through the synovial fluid.  
 
2.3.4 – Porous Scaffolds 
Many biological tissues are porous, which can be measured by the ratio of void space to 
the total volume of the sample. The porosity of biological tissues allows the transfer of blood, 
oxygen, and other nutrients. The tortuosity is the measurement of resistance fluid meets when 
FIGURE 2: MENISCAL DISPLACEMENT IS REPRESENTED BY THE DOTTED 
LINES (MM) (FOX, A. ET AL., 2011) 
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traveling through the pores. Galban, et. al. explored the proliferation of chondrocytes generated 
on a porous, polymer scaffold to be used for repairing joint damage. Porous scaffolds were 
explored so the scaffold could mimic biotransport of nutrients via diffusion, as the tissue would 
undergo in vitro so the cells can live (Galban et.al., 1999.) The degradation of the polymer was 
much assumed much slower than the proliferation of the cells and, therefore could be ignored. 
Other studies, such as that done by Hollister, S., utilize a biodegradable polymer in which the 
rate of degradation must be compared to the cell growth rate (Hollister, 2006.) When degradable 
polymers are used in scaffolds, the effects on the scaffold’s structural integrity must be taken into 
account with respect to the weight of the cells as they proliferate. The microstructures given by 
the porosity will give different effective stiffness and internal stresses. The porosity of the 
scaffold allows the necessary biological reactions to occur, as described above.  
 
2.4 – Histology Analysis 
2.4.1 – Viability Assays 
Cellular viability can be quantified through the use of various assays. Life Technologies 
makes a two part viability kit that distinguishes between live and dead cells. Live cells with 
intact membranes and esterase activity are tagged with calcein-AM and fluoresce green while 
dead cells are stained with ethidium homodimer-1 which fluoresces red. This makes for easy 
distinction between living and dead cells and results in great images using fluorescent 
microscopy. However the proper ratio of the two ingredients needs to be determined before using 
this technique because this changes from tissue to tissue (Life Technologies 2005).   
There is also a cytotoxicity colorimetric assay available from Abcam. The protocol calls 
for the assay solution to be incubated with cells as well as creating controls to compare to the 
cells. The assay is performed with microplates and a microplate reader sensitive at 570nm as 
well as 605nm. The ratio of absorbance at each wavelength is compared with the data from the 
controls and is used to determine percent cell viability (Abcam 2012). 
Lastly, there is a class of cell viability assays that involve transfecting the cells with a 
DNA sequence. A canonical method is the Luciferase assay, which uses the DNA of the 
bioluminescent enzyme from either fireflies (Metridia luciferase) or sea pansies (Renilla 
luciferase) (Konopka, 2010; Shifera, 2010). A DNA plasmid with the sequence can be expanded 
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in E. coli, and then added to the cell culture via transfection (Coombe, 1998; Konopka, 2010; 
Shifera, 2010). The enzyme emits a specific frequency of light immediately after being 
transcribed (509nm for Renilla and 690nm for Metridia) and quickly breaks down upon cell 
death (Coombe, 1998; Shifera, 2010). These two characteristics make luciferase ideal for use in 
cell viability or cell growth assays. 
2.4.2 – Destructive Analysis 
Immunohistochemistry is a novel strategy for the histological analysis of tissue 
engineered or natural cartilage. Antibodies can target components of the ECM that are important 
to the overall mechanical properties and type of cartilage. For instance, the fibrocartilage that 
composes the medial meniscus contains collagen types I and II, GAG, and aggrecan within the 
extracellular matrix. Antibodies can then be used to hybridize specifically to any one of these 
(Verdonk et al. 2005). Allowing florescent microscopy to be used to analyze tissue engineered 
cartilage and quantitatively compare it to images of natural cartilage (Zhang et al. 2004).  
Reverse transcription polymerase chain reaction (RT-PCR) can be used to measure RNA 
coding for constituents of the ECM produced by chondrocytes in tissue engineered cartilage. 
Levels of RNA can be compared between tissue engineered and natural menisci or even levels of 
RNA in different regions of the same tissue can be compared. In this process RNA is isolated, 
reverse transcribed into its complementary DNA (cDNA), and marked with a fluorescent tag so 
it can be quantitatively measure as it is being amplified in a fluorescently sensitive thermal 
cycler. Using this technique to measure gene expression in a tissue is a novel method for 
quantifying production of certain components of the ECM in tissue engineered cartilage (Park et 
al. 2006).     
Computer processing applied to microscopic images of stained cartilage can 
quantitatively analyze distribution of glycosaminoglycan (GAG) in cartilage. Staining tissue 
sections with safranin-O produces a red color. The intensity of this color in the microscopic 
images can be quantified and is proportional to the percentage of wet weight that GAG accounts 
for. Comparing the intensity of this color in low resolution microscopic images can be used to 
compare GAG densities and distribution between natural and tissue engineered cartilage (Martin 
et al. 1999). 
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2.4.3 – Non-Destructive 
Non-destructive and minimally invasive analysis techniques are currently being explored 
for use in many tissue engineering applications. Side viewing fiberoptic probes can be inserted 
into tissue engineered constructs or incorporated into scaffolds as the tissue is being cultured. By 
exciting and measuring fluorescent emission of tagged cells it is possible to confirm viability of 
inner cells while leaving the majority of tissue intact. The advantage of side viewing fiberoptics 
is that the probe can be rotated to excite cells and simultaneously image them around the probe 
instead of being limited to only being able to image the cells in front (Lima 2004).  
Ultrasound is also a novel technique when applied to analysis of tissue engineered 
constructs. This imaging modality can be used to determine if the tissue is homogenous 
throughout its composition, and it is also sensitive to biochemical indications of healthy cartilage 
which can be compared with ultrasound data from natural menisci. Other advantages of 
ultrasound include its relative inexpensiveness when compared to other medical imaging 
modalities, it doesn’t use radiation, and the equipment is often portable. However a big drawback 
of ultrasound is that it requires a lot of training to be able to produce good images (Shull, 
Chapter 3). For biomedical applications including imaging of tissue engineered cartilage, a 
transducer would be used to produce a frequency greater than 40 MHz. This frequency provides 
sufficient depth, 5 to 6mm, for current tissue engineering applications as well as the ability to 
characterize the tissue in terms of its biochemistry and fiber orientation (Hattori et al. 2003). 
 
2.5 – Cell Culture 
2.5.1 – Overview 
 The primary cells which produce cartilage are called chondrocytes. There are three major 
types of cartilage: elastic cartilage, hyaline cartilage, and fibrocartilage (Mow et al., 2005).  Each 
is characterized by the composition of its extracellular matrix, or ECM. The ECM of cartilage is 
essentially a proteoglycan gel suspending a dense network of protein fibers (Mow et al., 2005). 
The properties of these fibers are dependent on the cartilage type. Elastic cartilage is mainly 
composed of elastin and forms external cartilaginous tissues such as the ear, while the fibers of 
both hyaline cartilage and fibrocartilage are formed by different types of collagen, types II and I, 
respectively (Hall, 2005; Mow et al., 2005); Hyaline Cartilage covers the surface of joints and 
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primarily serves to reduce friction, while fibrocartilage is found in the meniscus, ligaments, 
tendons, and the spinal discs (Hunter, 2011). The primary cell type for all types of cartilage is 
chondrocytes. Fibrocartilage-producing cells are further classified as Fibrochondrocytes, because 
their morphology differs slightly from the others and have some characteristics of fibroblast cells 
(Mow et al., 2005). There are three major methods to culture chondrocytes: primary cells, 
mesenchymal stem cells, and carcinoma-derived cells. 
2.5.2 – Primary Chondrocytes 
Ideally, chondrocytes from a primary animal source would be used (i.e. meniscal tissue, 
spinal discs, ligaments, or tendons). These primary cells are the closest one can get to the actual 
tissue found in the meniscus. However, there are several problems with these cells. These are 
terminally differentiated cells, which make them difficult to culture in vitro, and they will die off 
once reaching their Hayflick limit (Mo et al., 2009). Additionally, there is a large cost associated 
with maintaining the animal and with harvesting the chondrocytes each time they are needed for 
an experiment, and the chondrocytes begin to lose their cartilage-like phenotype when grown in 
a traditional monolayer culture (Tsuchiya et al., 2004). 
2.5.3 – Mesenchymal Stem Cells 
A more recent and attractive option is the use of stem cells, specifically mesenchymal 
stem cells. Mesenchymal stem cells are the progenitors to a number of tissues, including bone, 
cartilage, adipose, muscles, tendons, and ligaments (Chamberlain et al., 2007). Unlike primary 
chondrocytes, MSCs can be cultured for long periods of time in an undifferentiated state, and 
then transformed into the desired cell lineage via media conditions (Chamberlain et al., 2007; 
Mow et al., 2005; Tsuchiya et al., 2004). However, the traditional source of MSCs, bone 
marrow, appears to lose its ability to specifically form chondrocytes the longer the cells are kept 
in an undifferentiated state (Tsuchiya et al., 2004). Additionally, it can be difficult to derive the 
correct cell line from MSCs, since there is no one canonical protocol for differentiating the cells 
and the differentiating capacity can be influenced by a number of variables, including cell source 
and time spent in culture and the source of the MSCs: for example, it may be more difficult to 
induce chondrogenesis in adipose-derived mesenchymal stem cells (Chamberlain et al., 2007; 
Liu et al., 2009; Tsuchiya et al., 2004). In the past decade, mesenchymal stem cells have been 
isolated from synovial tissue in joints (Fan et al., 2009). These Synovial MSCs are believed to 
have a much higher chondrogenic potential than MSCs derived from other tissues, and there 
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have been several studies into their chondrogenic potential (Fan et al., 2009; Varshney et al., 
2010; Katagiri et al., 2013). However, all of these studies isolated the synovial MSCs from a 
primary source, and there do not appear to be many commercially available cell lines. Some 
studies have looked into getting past the difficulties of both correctly differentiating 
mesenchymal stem cells and with culturing primary cells by co-culturing both cells, testing the 
hypothesis that the primary chondrocytes will influence the differentiation of the mesenchymal 
stem cells (Mo et al., 2009; Tsuchiya et al., 2004; Varshney et al., 2010). 
2.5.4 – Cancer-Derived Cells 
The third option is to use a cancer-derived cell line. The two major drawbacks of using a 
cancerous cell line are that the cells cannot be used in an animal model and sometimes show very 
unusual cellular characteristic due to mutations. Additionally these cells are unusable for a 
clinical application because they are derived from cancer. However, these same unusual cellular 
characteristics can lead to cell lines with properties that are normally difficult to obtain and the 
cell line can typically divide indefinitely, unlike both primary cells and mesenchymal stem cells. 
Research was conducted on two mouse cancer cell lines: C3H/10T1/2 and ATDC5. C3H/10T1/2 
cells were derived from an embryonic sarcoma, have a fibroblastic morphology, are a good 
transfection host (meaning they could be infected with a cell-viability marker), and have shown 
the ability to differentiate into type II collagen-producing chondrocytes (Denker et al., 1999; 
Haas et al., 1999).  However, the cells are only usable for experimentation between passages 5-
15, or ~50 days, which makes them unattractive for studies that will require culturing over a 
longer time frame (C3H/10T1/2).  This eliminated C3H/10T1/2 as a choice, since a longer time 
period will be required to expand the cells sufficiently for our experiments. The second cell line, 
which is being used in this study, is ATDC5, a chondrogenic cell line derived from an embryonic 
teratocarcinoma that has an epithelial-like morphology (Shukunami et al., 1996, 1997; ATDC5). 
It can be maintained in an undifferentiated state, and when treated with specific growth factors 
will sequentially differentiate into cartilage and then bone (Shukunami et al., 1997; Yoshikawa 
et al., 2013). However, the progression into bone can be chemically inhibited by treatment with 
parathyroid hormone or an iron overload which leave it in a chondrogenic state (Shukunami et 
al., 1996; Ohno et al., 2012). 
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2.5.5 – Growth Factors for Chondrogenesis 
 One of the major issues with culturing chondrocytes is that, even if the correct cell type is 
obtained, chondrocytes begin to de-differentiate when grown in traditional cultures (Tsuchiya et 
al., 2004). There has been extensive research into the different factors which induce 
chondrogenesis and maintain cell phenotype. In 2008, Johns and Athanasiou studied the effects 
of five growth factors on the collagen production and differentiation of coastal chondrocytes 
(isolated from a rib) and found that treatment with insulin-like growth factor I increased cell-
number and induced a fibrocartilaginous morphology (John, 2008). Several studies have 
examined the effects of the Bone Morphogenic Protein family on cartilage regeneration and 
differentiation of stem cells with results pointing to BMP-2 and -4 having the capability to 
induce chondrogenesis in MSCs (Kuroda, 2006; Sekiya, 2005; Steinert, 2003). Several studies 
have also looked into using the family of Transforming Growth Factors, specifically the varieties 
TGF-β, to induce differentiation with mixed results: some studies say that the use of TGF-β 
caused differentiation, while other studies claim it had no effect (Johns et al., 2008; Kuroda, 
2006; Sekiya, 2005; Varshney et al., 2010). Lastly, Angele et al has conducted studies on the 
effects of environmental mechanical stimulation, through both hydrostatic pressure changes and 
compression, and determined that cyclic mechanical stress increases mesenchymal stem cells’ 
chondrogenic capability (Angele, 2003, 2004). 
3 – Project Strategy 
This project explores the possibility of growing a cartilaginous thick tissue culture by 
seeding a 3D printed, biodegradable scaffold with a chondrocytic cell line. The following chapter 
outlines the objectives and constraints of our project as well as the approaches used to obtain 
them. 
3.1 – Original Client Statement 
Each knee joint has two, three-dimensional cartilaginous structures that provide shock 
absorption, stability, and lubricity to the knee; the lateral and medial menisci. Meniscal tears and 
ruptures are common injuries that often experience difficulty healing. The team will engineer a 
three-dimensional, biomorphic tissue scaffold to research the ability to grow, ex vivo, 
replacement menisci. This scaffold will be printed with a commodity 3-D printer modified and 
re-engineered as necessary by the team to provide higher resolution. 
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3.2 – Objectives 
Through a combination of team discussion, background research, and review of the initial 
client statement, we were able to determine the projects objectives and constraints. The five main 
objectives of this project include maintaining proper geometry, cell viability, rapid production, 
biodegradability, and sterility of the scaffold design. An objectives tree, shown in Figure 3, 
outlines the objectives and their sub-goals. 
 
 
FIGURE 3: OBJECTIVES TREE 
3.2.1 – Objectives Overview 
● Proper Geometry: Final scaffold must generate a tissue with the correct geometrical  
biomechanical properties. The material properties and porosity of the scaffold will dictate 
cell growth and viability. 
● Viability: The thick tissue culture should be viable in terms of histology and free from 
necrosis. In order for the design to be deemed successful, the tissue engineered construct 
should contain viable cells throughout all layers of the scaffold. 
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● Rapid Production: Must be able to quickly generate scaffolds with a commercial 3D 
printer. Additionally, the scaffold structure should be consistent across multiple printings 
and different types of printers. 
● Biodegradable: Scaffold must be non-toxic and degradable in a biological environment. 
The degradation rate of the scaffold will be tailored to tissue growth by material 
selection. 
● Sterility: Scaffold must be sterilized after printing and during culturing. Ideally, the 
scaffolds would be in a controlled, sterile environment while printing but due to the scope 
of this project and laboratory limitations, sterilization of scaffolds after printing and 
before culturing should be sufficient. 
3.2.2 – Quantifiable Objective Comparison 
After defining and outlining the objectives for this project, a quantifiable method must be 
used to compare their importance. A Pairwise Comparison Chart (PCC) is used to determine the 
importance of each objective relative to one another. The PCC in the table below quantifiably 
compares the objectives outlined in the previous section. Upon completion of the PCC, the group 
determined that cell viability and ensuring proper geometry, with scores of 3.5 and 3 
respectively, were of utmost importance for this project’s final scaffold while biodegradability, 
sterility, and rapid producibility were then ranked less important in that order. The results from 
the PCC refocuses the scope of the project and determines what objectives must be fulfilled and 
which may be sacrificed in the project’s development.  
TABLE 3: PAIRWISE COMPARISON CHART 
 Proper 
Geometry 
Viability Rapid 
Production 
Biodegradable Sterility Total 
Proper 
Geometry 
 .5 1 1 .5 3 
Viability .5  1 1 1 3.5 
Rapid 
Production 
0 0  0 0 0 
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Biodegradable 0 0 1  .5 1.5 
Sterility .5 0 1 .5  2 
 
3.3 – Constraints 
The group identified four constraints they must consider when moving forward with this 
project. These constraints include:  
● accurate 3D printer fidelity  
● usage of a non-human cell line 
● non-destructive cell viability testing 
● costs within budget 
The 3D printer must be able to accurately print a scale at a scale of 2/10 mm. Acquisition of 
human cells for viability testing is beyond the capacity of this project and the group is limited to 
ATDC5 mouse chondrocytes. 
Viability testing is both an objective and a constraint due to the need to test for cell 
necrosis without destructive testing. We must develop a nondestructive test to determine the cell 
viability within the core of the scaffold. The budget for this project is approximately $550.  The 
initial cost for the MakerBot® was $2500, while the costs for our chosen cell line and viability 
testing kits are approximately $650. Our budget must be limited to printer modifications and the 
purchase of the polymers used to create our scaffold. Additionally, a combination of 
computational limitations, hardware malfunctions, and time constraints served to limit the scope 
of this project to a “proof of concept.” Rather than attempting to reproduce the geometric and 
mechanical properties of the meniscus, The team focused on generating a 3-Dimensional 
Scaffold which could grow viable thick tissue cultures that could in the future be used as a basis 
for meniscal regeneration. 
3.4. Revised Client Statement  
 The team will engineer a three-dimensional, biomorphic, biodegradable, biocompatible 
tissue scaffolds and research the scaffolds ability to grow, ex vivo, thick tissue culture which can 
proliferate and differentiate cells beyond the typical nutrient penetration barrier. This scaffold 
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will be printed with PLA on a commodity 3-D printer, modified and re-engineered as necessary 
by the team to provide higher resolution. 
3.5 – Project Approach 
The purpose of this study is to generate a biodegradable scaffold which can be seeded 
with cells and used to grow thick tissue culture in vitro. Porous scaffolds with differing 
geometries will be generated for experimentation with cells. These scaffolds will be composed of 
PLA so that the scaffolds will be biodegradable and printable on the 3D printer. The effect of 
porosity and shape on thick tissue culture success will be determined through multiple 
experiments with cell culture. 
 The cell line to be used is ATDC5. Experiments will be conducted to optimize the cell 
line’s differentiation into the cartilage producing cells, chondrocytes and fibrochondrocytes. 
Once the ideal conditions for culturing/differentiating ATDC5 cells are determined, the cells will 
be seeded onto the porous scaffolds using a collagen hydrogel. The amount of hydrogel, amount 
of cells, and cross-linking method will need to be optimized. 
Given the budget and time allotted for this major qualifying project, some aspects need to 
be simplified for the group to establish a proof of concept. Instead of designing and constructing 
a bioreactor to increase nutrient perfusion, the seeded scaffolds will be cultured on a shaker table 
inside the incubator. This agitation will help nutrient perfusion as well as allow the geometry of 
the scaffold to be the limiting factor. This allows the success of the tissue engineered construct to 
be dependant on the scaffold geometry more than the bioreactor it was cultured in.  
 Once we have seen that cartilage (cell differentiation?) has been grown, it will need to be 
histologically tested. In addition to the viability testing during and after culture, some of the 
biological structures will be cryogenically frozen and sectioned with a microtome. Different 
histological tests will be performed and this will allow for microscopic analysis of the 
distribution of internal cells.  
3.6 Biocompatible material  
 The 3D printer that was initially used for this project was the MakerBot® Replicator, a 
commercially available dual extrusion printer. The Replicator can print a variety of different 
filaments that include polylactic acid (PLA), polyvinyl alcohol (PVA), and acrylonitrile 
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butadiene styrene (ABS). As the project moved forward the group began to use a Replicator 2 as 
the main printer for the printing of all scaffolds. The Replicator 2 can print using the same types 
of filaments as the Replicator. As required for this project the material used in printing the 
scaffold must be biocompatible and biodegradable. ABS is neither biocompatible nor 
biodegradable and will not be used for this project.  
 4. Methods and Design Alternatives  
 This project contains many parts and is very multi-faceted. It combines elements of 
mechanical engineering for the 3D printer work, computational design for designing the scaffold 
and working with the printer software, biology for the cell culture, and biochemistry for 
histological analysis. The team therefore incorporated an extensive about of methodologies and 
possible designs/protocols into the project. These methods and alternative designs are discussed 
in the following chapter. 
4.1 3D printer modification 
4.1.1 MakerBot® Extruder Nozzles 
 The Replicator is commercially available with extruder nozzles that can extruder filament 
at a size of .4 mm. Smaller size nozzles are not commercially available from the MakerBot® 
company and must be either purchased from other companies or custom made. This presents a 
problem to achieve an optimal tissue ingrowth and proliferation, which occurs when a scaffolds 
design has pore sizes ranging from 200 - 400microM and having a 50% void fraction (Hsu, et al. 
2011; Tareoka, et al. 2010). This pore size cannot readily be achieved using the standard .4mm 
replicator nozzle and smaller nozzles, with diameters of .2mm or .25mm, will have to be 
acquired. A previous MQP group that had worked on a similar project had acquired CAD 
drawings of custom designed nozzles from MakerBot® and had multiple nozzles machined at the 
WPI machine shops for use with the Replicator. The team would use the original set of extruders 
that had been custom made and would also acquire the CAD drawings for the creation of more 
nozzles for any further testing. 
4.1.1.1 Acquiring Smaller Extruder Nozzles 
The team initially looked at having different outside machining companies either create 
the extruder nozzle blanks, which would then be sent to a company for drilling, or create the 
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extruder nozzles and drill them as well. Multiple companies were looked at to machine the 
extruder blanks but none were able to manufacture the extruder blanks.  
Since an outside company was not able to machine nozzle blanks for the project the 
group registered the project with the Washburn Shops here on campus. The CAD drawings of the 
nozzles were sent in with the groups’ registration and all that was left to do was to wait for the 
registration to go through with the Washburn Shops. The group was finally contacted by our 
appointed staff member in Washburn Shops but after sending an initial email we heard no word 
back about moving forward with getting any nozzles machined on campus. It was at this point in 
the project that it was becoming apparent that the group would have little time to machine and 
bore new nozzles and that our primary focus would need to be on the printing of scaffolds. 
After talking with Jessie Halter, a member of a previous MQP group, the group was 
directed to a website called www.qu-bd.com. This website sold extruder nozzles compatible with 
the Replicator The group then purchased four nozzles with a orifice diameter of .25 mm. Two of 
these nozzles would be used for printing purposes while two could be set aside for any further 
printer modifications. This will allow the group to perform any experimentation with the nozzles 
to increase the resolution of the final print, time permitting. For the duration of the project the 
nozzles used with the Replicator were the .25 mm nozzles acquired online from www.qu-bd.com 
and the nozzles used by the previous year’s MQP.   
4.1.2 MakerBot® Replicator Problems  
 During the course of printing scaffolds, problems with the printer began to occur and the 
group was initially unable to determine the source of these problems. We initially believed that 
the print settings of our scaffolds needed to be optimized for the prints to be successful. 
Modifying the print settings did not lead to a successful print, even when print settings from a 
previously successful MQP were used. These failures prompted the group to look at other 
reasons for why the prints were failing and initial ideas were that the extruders needed to be 
cleaned. Upon subsequent cleaning two problems were noticed by the group; one, that a small 
Delrin plunger responsible for pushing the filament up against the actual extruder was not 
working properly, and two, that a small piece of the printer that caused the extruder to rotate 
properly was loose within its housing.  
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To keep the small piece of the printer secured in the printer, it was re-tightened into the 
drive shaft. This solved the problem of the extruder not rotating properly when the printer was 
running during a print. Solving the problem with the Delrin plunger proved to be harder than 
expected as that part of the printer was no longer available for purchase anywhere. The Delrin 
plunger is a small piece of the Replicator that pushes filament up against the extruded and causes 
the filament to get caught and pushed into the extruder nozzle. If this part is not functioning 
properly then no filament will actually extrude during a print. This part is made of an easily 
degradable polymer and will become worn down after a period of use in the Replicator. Since no 
new Delrin plungers were available for purchase the group 3D printed replacements. .STL files 
for the part were found on www.thingiverse.com and two plungers were printed using other 3D 
printers found on campus.  
These printed parts were not the same quality as the original prints and had to be slightly 
modified to try and get them to work properly when placed within the printer. These replacement 
plungers worked initially but filament extrusion was slow compared to when the original plunger 
was working properly and filament extrusion seemed to stop at different point during a print. An 
alternative method of fixing the problem with the extruder was researched and it was found that 
an extruded upgrade kit was available for purchase online. This upgrade kit replaced the Delrin 
plunger entirely with two solid steel rollers that would push the filament through the extrusion 
nozzle using a spring tension system. This upgrade kit was successful in extruding filament 
during a print but the prints continued to fail during the printing process. It was at this time that it 
was decided that acquiring scaffolds was a top priority for the team and that alternative methods 
of printing scaffolds should be researched.  
4.1.2.1 Alternative Printing Methods 
 The group began asking around campus to discover if there were 3D printers they could 
use to print scaffolds. There were two 3D printers in the Mechanical Engineering Department but 
these could not be used as both printers were Objet printers and only printed in resin, a material 
not suitable for use in a biodegradable scaffold. The group visited the WPI Collablab, as it was 
known that members of the organization worked with 3D printers, but discovered that the 
printers built by members of Collablab were unable to print at the desired resolution of this 
project. 
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 After discussing the need to find a better 3D printer with another MQP group it was 
discovered that Professor David Planchard was in possession of two Replicator 2 printers. 
Professor Planchard was approached about the possibility of using his printers to print scaffolds 
and he agreed, we only had to bring him an SD card with our scaffold files that we required to be 
printed. The team was able to acquire multiple scaffolds with Professor Planchards help before 
he could no longer let us use his printer, as he required both printers to finish his MQPs.  
While the team used Professor Planchards’ printers to print scaffolds we continued to 
look for other means of producing scaffolds for when we would no longer be able to use those 
printers. A member of our team was put in contact with Cathy McEleny at Draper Laboratories. 
The team was told that they would be able to help us print more scaffolds and it was learned that 
a Replicator 2 was available for use at their Rapid Prototyping Center in Boston. Two members 
of the team traveled to Draper Laboratories and were successfully able to print scaffolds after 
modifying the print settings. The team plans to continue visiting Draper Laboratories to print 
more scaffolds for use in future cell seeding tests.                
4.1.3 MakerBot® Software 
Before any of the scaffolds could be printed all the CAD files needed to be converted to a 
specific type of file known as an .stl file. Any object that contains a circular or rounded section 
cannot be properly printed by a 3D printer, as the printer deposits material along a series of 
points and anything that is rounded can have an infinite number of points for the printer to 
calculate for. Creating an .stl file resolves this technical problem by converting the entire CAD 
file into a set of triangles that 3D printing software can use to calculate the route the filament 
extruder will take while depositing material. The smaller the amount of triangles generated in the 
.stl file the “coarser” the final printed object will be while a larger amount of generated triangles 
will increase the quality of the final print. 
 Once these .stl files have been created they are then used to generate a specific code that 
the 3D printer will use to print the scaffold. There are a multitude of softwares that can be used 
to generate these codes and MakerBot® Replicator accepts codes generated by three different 
types of software, Thing-O-Matic, ReplicatorG, and MakerWare. Going off the advice of Nick 
Trebucco, the one who allowed the group to use his printer, we used to ReplicatorG as the 
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software to generate our printing code, or G-code as it is called when using that specific 
software. The version of the software used for this project was ReplicatorG 0037.  
ReplicatorG offers a variety of printing options which can be modified to alter the final 
printed object. The printing options that can be modified using ReplicatorG are separated into 
sections; general settings, plastic, and extruder, as well as general options for the creation of the 
G-code. For the general options there is the choice to choose which extruder will be used during 
the print, either the right or the left extruder, whether to use a raft or support for the print, and 
whether to use ReplicatorG default start and end code or whether to Print-O-Matic code 
generation. During this project both the right and left extruder were used as we modified the 
printer and no supports or rafts were needed during the printing of the scaffold. The default start 
and end code were used for the G-code as the Replicator used for this project did not use stepper 
extruders.  
The settings section of ReplicatorG is where the most modifications can be done to the 
G-code used to print an object. The settings that can be modified include object infill, layer 
height, number of shells, feed-rate, and travel feed-rate. The object infill setting will determine 
the final density of the print, with an object infill of 100% leading to a completely solid object, 
while an object infill of 0% will print a hollow object. Layer height determines the width of each 
layer of filament that is laid down by the printer during a print. The default layer height is .27 
mm in ReplicatorG software. The number of shells refers to the thickness of the printed object. 
Every object automatically has one shell for its initial thickness and each additional shell adds to 
the thickness of the final print. The feed-rate and travel feed-rate deal with how fast the extruder 
travels, either when the filament is being extruded or when the extruded is moving between 
extrusions. Feed-rate is the speed at which the extruded moves when filament is being extruded 
during a print while travel feed-rate is the speed at which the extruder moves while it is not 
extruding filament. Both feed-rate and travel feed-rate are set in units of mm/s.  
    For the intended size of our scaffold, being approximately 10 mm x 10 mm x 10 mm, 
or the corresponding modular sections being approximately 10 mm x 10 mm x 3 mm, there 
would essentially be no void space, and object infill was set to 100% for the G-code. For layer 
height we experimented with variable heights, ranging from .2 mm to the standard of .27 mm to 
see which option would give the greatest fidelity in our scaffold print. The number of shells was 
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left at the default of one shell for most prints, but zero shells were used upon learning that a 
previous MQP have achieved successful results with that setting. The default feed-rate and travel 
feed-rate are to 40 mm/s but we had more success with much slower feed-rates, with our feed-
rate and travel feed-rates set in the ranges of 5 - 15 mm/s.  
The next two sections that allow for modification of the G-code include changing the 
filament diameter and extruder nozzle size. Changing the filament diameter in the G-code will 
determine how much filament is actually extruded from the nozzle. The actual diameter of 
filament that is used in all MakerBot® 3D printer is 1.75 mm, but the filament may swell slightly 
due to exposure of moisture in the air over time. The filament diameter is automatically set to a 
value of 1.82 mm in ReplicatorG to account for this possible swelling and the minute tolerances 
in the stock filament. Increasing or decreasing this value can affect how much filament is 
actually fed through the extruder during a print. The greater the value inputted into the G-code 
the lower the amount of actual filament that will actually be extruded, as the machine will not 
feed in as much filament to begin with. The lower the inputted value the greater the amount of 
filament that is extruded, as the machine will believe there is a smaller amount of filament being 
fed into the extruder and will increase the output to generate the required volume of filament. 
The final option that can be modified in ReplicatorG is the nozzle diameter. Any value could be 
entered here and that would help determine the amount of filament that would be extruded 
during a print.  
For this project the filament diameter was tested at values ranging from 1.82 mm, the 
default setting in ReplicatorG, to 2.10 mm. This was to see which filament setting would allow 
for an optimal print while creating thinner filament layers.  
4.2 Scaffold Design 
The main objective for designing the scaffold was creating an optimal geometry which 
allows continuous nutrient flow to all layers of cells. Previous work conducted by our colleagues 
(One of the previous MQPs) has shown that biodegradable scaffolds made with high volume, 
high surface area, 3-dimensional fractal shapes, can provide the required nutrient flow to allow 
thick tissue culture.  
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4.2.1 Fractal Generation 
Several processes were examined to generate fractal structures for use in the printed 
scaffold. The first was to directly model fractal-like shapes using a CAD program such as 
SolidWorks. This was the most straightforward method, but only allowed for the creation of 
simple fractals such as the Menger Sponge and was very labor intensive. However, this method 
also allowed for direct modification and manipulation of the scaffold and smooth conversion to 
the printable STL file format. 
 A second option was to use a computer program to procedurally generate a fractal that 
could be converted into a workable CAD file. The converted file could then be modified into the 
desired scaffold shape and converted into an STL file. The primary advantage of this method is 
that it allows the user to quickly generate many complex fractal shapes. However, the programs 
and especially the file conversion can be very processor-intensive, and many of the programs 
require a good working knowledge of fractal mathematics. The team primarily examined the 
program Incendia (http://www.incendia.net), which is a free 3D fractal generator. The program 
uses voxels (essentially “3D Pixels”) to generate fractals based on a preset list of fractal 
equations. The results shapes can be exported as an STL file. 
 The third option explored by the team involved using open-source, premade 3D fractals 
available on 3D Printing websites such as www.thingiverse.com. These files have the advantage 
of being completely pre-fabricated and available in the printable STL format. Because these were 
“ready-to-print” files, modifying them required the processor-heavy conversion into a workable 
CAD file. Additionally, these files often contained errors (e.g. features on adjacent faces were 
not aligned correctly). 
4.2.2 Gross Scaffold Structure  
 While the proper internal scaffold geometry allows the seeded scaffold to sustain viable 
growth, the overall scaffold shape dictates the shape of the resulting tissue grown from the 
scaffold. The gross shape of the scaffold should, therefore, resemble the geometry of the lateral 
meniscus, discussed previously in section 2.2.1 of this report. The fractal-like internal geometry 
is either imported into a CAD file, as mentioned in the previous section, or is generated directly 
in the CAD software, first so the gross scaffold shape could then be carved out of the fractal 
block.  
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4.2.2.1 File Conversion  
 All of the fractals generated in Incendia and obtained from open source sites were in the 
printable STL format. However, this format only contains surface information and is completely 
unmodifiable in traditional CAD programs. In order to convert these files into a modifiable form, 
such as a SolidWorks Part (.sldprt), the team examined and designed several conversion 
protocols. 
 The SolidWorks add-on Surface Mesh Editor is made to process the data obtained from 
3D Object Scans from surfaces into workable solids. The team attempted a number of trials with 
this add-on, with no success. While the process works for surfaces, it was unable to reconcile the 
voids and complex geometries of a 3D fractal. Below is a simple example of an STL file 
generated with OpenSCAD (a code-based CAD program). 
 
FIGURE 4: SIMPLE "SPHERE-IN-CUBE" GENERATED IN OPENSCAD 
When put through the SolidWorks surface mesh process, it becomes one of the following (for the 
guided and automatic processes, respectively). 
                                                       
FIGURE 5: ERRORS IN SOLIDWORKS SURFACE MESH CONVERTED. LEFT - GUIDED PROCESS; RIGHT - AUTOMATIC 
PROCESS 
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While the object on the right has the right shape, it does not have any editable features, and 
disappears if the file is reopened. 
 Due to the issues with the built in SolidWorks processing, the team generated an original 
protocol using the Autodesk Inventor Surface Mesh Processor, a newly released add on for 
processing surfaces into solids. The Surface Mesh Processor was used to convert an STL file into 
an Inventor Part File (.ipt), which was then converted into a .sldprt file so that the time could 
work with it. While this process worked with moderately complex fractals, it is extremely 
processor intensive, with total times up to 12 hours. The team eventually decided to use the 
fractals modelled directly in SolidWorks due to the ease of creation, modification, and 
processing. 
4.3 Alternative Scaffold Designs 
 The group initially looked at using a third level recursion cylindrical Menger Sponge 
scaffold design. The third level of recursion would allow for a large surface area to volume 
ration, which would increase nutrient delivery to cells within the scaffolds core. The group also 
design a second level recursion spherical Menger Sponge, with spheres being used in place of 
cubes to connect each pore. Spheres and cylinders were used in these designs to remove the 
straight surfaces that are prevalent in a typical Menger Sponge fractal. Cells do not grow well on 
either sharp surfaces and this necessitated the change of design of the Menger Sponge. A custom 
designed Menger Sponge was also created by the group as another design alternative. This 
scaffold design was a second level recursion cylindrical Menger Sponge design with modified 
pores sizes.   
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FIGURE 6: DIFFERENT MENGER SPONGE FRACTALS. LEFT - 3RD LEVEL MENGER SPONGE; RIGHT - 2ND LEVEL MENGER 
SPONGE 
When trying to processing the third level recursion cylindrical Menger Sponge the group 
did not have enough computational overhead and was unable to print that design. This 
necessitated the group to begin working with the second level spherical Menger Sponge in the 
hopes that the group would have enough computational overhead to process the design. This 
design was successfully processed but the team was unable to successfully print the scaffold to 
completion. Working with the second level recursion cylindrical Menger Sponge the group was 
able to successfully process and print the scaffold design.    
4.4 PLA Degradation Methodology 
 In a similar way that errors in printing can result in more texture in the scaffold, the way 
each scaffold degrades over time can result in more texture and be beneficial to the design as a 
whole. To test this PLA scaffold cubes were weighed and submerged in distilled water. These 
cubes were maintained at 37° C and removed from the water on days 1, 7, 14, 21, and 28. 
Testing the degradation of this material over the timeframe of the ATDC5 cells is important for 
planning the scaffold seeding methodology. 
4.5 ATDC5 Differentiation Protocol  
 The ATDC5 differentiation protocol begins with supplementing the maintenance media 
with ascorbic acid for 7 days. This addition of this to the media allows the cells to create more 
collagen in the extracellular matrix. Growing the cells in the presence of this increased levels of 
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collagen differentiates them into pre chondrocytes. The ascorbic enhanced media components 
and concentrations can be seen in the table below.  
TABLE 4: ASCORBIC ACID ENHANCED ATDC5 MEDIA 
DMEM 44% 
Ham’s F12 44% 
Fetal Bovine Serum 10% 
Penn/Strep 1% 
Glutimax 1% 
Ascorbic acid 37µg/ml 
 
 The final step in the differentiation process is the addition of insulin to the ascorbic 
enhanced media. The ATDC5 prechondrocytes are culture in this media for 21 days which 
differentiates them into the final chondrocytes. At some point in the differentiation process the 
cells will stop dividing when they are fully differentiated. The final differentiation media 
components and concentrations can be seen in the table below. 
TABLE 5: ATDC5 DIFFERENTIATION MEDIA 
DMEM 44% 
Ham’s F12 44% 
Fetal Bovine Serum 10% 
Penn/Strep 1% 
Glutimax 1% 
Ascorbic acid 37µg/ml 
Insulin 10µg/ml 
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4.5.1 BrdU Assay 
 Bromodeoxyuridine, commonly abbreviated BrdU, is a nucleotide analog which is often 
used to detect cell proliferation. During the S phase of the cell cycle, DNA is synthesized and 
BrdU can be incorporated into the new chain in the place of thymidine. Generally cells are 
exposed to the same amount of BrdU for a set period of time to control the number of cells going 
through the S phase for each time point. Cells can be fixed after the BrdU incorporated into the 
DNA, and BrdU specific antibodies allow for the use of fluorescent tags to show newly created 
DNA in the nucleus of the cells. Comparing the number of fluorescently tagged nuclei to total 
number of cells shows how many cells are proliferating. Cells were cultured using the ATDC5 
differentiation protocol to learn when the cells stop dividing.  
4.5.2 Alcian Blue Staining 
 Alcian blue staining solution (Scytek, pH 2.5) is a common method to confirm 
chondrogenesis of cells. Alcian blue stains blue for acidic polysaccharides deposited into the 
extracellular matrix. These acidic polysaccharides include glycosaminoglycans as well as other 
proteoglycans. Using this for the ATDC5 cell line can determine when in the differentiation 
process they become chondrocytes which will allow for better planning for the 3D cell culture 
within the PLA scaffolds. This stain can also be used on the cells within the scaffold to test the 
final tissue engineered construct for chondrogenesis.  
4.5.3 Modified Serum Levels 
 Given the results of the BrdU experiments that showed half of the cells were still dividing 
up until the last day of the differentiation protocol, an experiment was devised to explore the 
possibilities of a modified serum protocol to slow the proliferation of these cells and allow them 
to differentiate sooner. The modified protocol uses the same media changes, ascorbic 
concentrations, and insulin concentrations as the standard protocol but at day 7 the fetal bovine 
serum is reduced from 10% to 2% with an additional 2% adult horse serum. The table below 
shows the components and concentrations of ATDC5 modified differentiation protocol with 
lowered FBS and AHS.  
 
TABLE 6: ATDC5 DIFFERENTIATION MEDIA WITH REDUCED FBS AND 2% AHS 
DMEM 47% 
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Ham’s F12 47% 
Fetal Bovine Serum 2% 
Adult Horse Serum 2% 
Penn/Strep 1% 
Glutimax 1% 
Ascorbic acid 37µg/ml 
Insulin 10µg/ml 
 
 On day 10 of culture the media contains no fetal bovine serum and only contains 2% 
adult horse serum. This media is used for the duration of of the modified differentiation protocol 
in an effort to slow division of the ATDC5 cells and promote early differentiation. The table 
below shows the components and concentrations of this media. 
TABLE 7: ATDC5 DIFFERENTIATION MEDIA WITH 2% AHS 
DMEM 48% 
Ham’s F12 48% 
Adult Horse Serum 2% 
Penn/Strep 1% 
Glutimax 1% 
Ascorbic acid 37µg/ml 
Insulin 10µg/ml 
 
 
4.6 Hydrogel Protocol 
 PureCol EZ Gel (Advanced Biomatrix) was chosen as the hydrogel to seed the 3D printed 
scaffolds. This is due to previous success that the 2012-2013 major qualifying project team had 
in using it. In their experience the simple protocol let to the creation of a uniform gel and good 
results from experimenting with it. It is a bovine sourced type I collagen solution which forms a 
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hydrogel when incubated at 37° C for 90 minutes. Collagen I concentration for this product is 
5mg/ml or 0.5%. This is ideal for this project not only because it is simple to work with, but also 
because a collagen gel should lead to an early or easier differentiation into chondrocytes for the 
ATDC5 cells selected for the project. 
4.6.1 Cellular Distribution Methodology 
 Given the time it takes the PureCol EZ Gel the form a hydrogel (90 minutes), it is 
important to consider cellular distribution when developing and improving upon our seeding 
protocol. A cell and hydrogel mixture was maintained at 25 degrees Celsius, and experimental 
groups were added to a 96 well plate every 10 minutes and incubated at 37 degrees Celsius to 
form a gel.  
4.6.2 ATDC5 Differentiation in Collagen Hydrogel 
 The principal behind the ascorbic acid accelerated differentiation protocol is that the cells 
are able to produce higher levels of collagen which helps them to differentiated into 
chondrocytes sooner than the standard differentiation protocol. Even though the PureCol EZ gel 
is a type I collagen compared to the type II that the ATDC5 chondrocytes produce, the growth 
and differentiation of these cells in the hydrogel will differ compared with how they behave on 
tissue culture plastic. To test this cells were seeded in the hydrogel along with a control group of 
cells on tissue culture plastic. Both of these groups were given the ascorbic accelerated 
differentiation protocol and even before the addition of insulin at day 7 there were morphology 
changes noted in the cells grown in the collagen based hydrogel. Below is a comparison of the 
cells in the hydrogel and those grown on tissue culture plastic.  
4.7 Scaffold Seeding Methodology 
 Scaffold, custom printed wells, and forceps used to seed the scaffolds were sterilized 
through soaking in isopropyl alcohol and exposed to UV light for 2 hours to ensure there would 
be no contamination while the scaffolds were being cultured. Forceps and plastic scoopulas used 
to maneuver and remove the seeded scaffolds from the wells the washed with DPBS to remove 
isopropyl alcohol before being used to handle the seeded scaffolds. The figure below shows the 
sterilization process before the scaffolds were seeded.  
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FIGURE 7: STERILIZATION DURING SEEDING PROCESS 
Single scaffolds along with modular scaffolds were used for testing. The modular 
scaffolds were seeded as two separate parts and held together with the hydrogel. Distinct seeding 
wells for single and modular scaffolds were created to minimize loss of the collagen hydrogel. 
After sterilization scaffolds were placed in wells and covered with a cell-hydrogel solution. 
These seeded scaffolds were then transferred to the incubator for 90 minutes at 37 degrees 
Celsius to form a solid gel. Below is an image of the seeded scaffolds before after they were 
removed from the incubator.  
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FIGURE 8: SEEDED SCAFFOLDS IN WELLS 
 Scaffolds were carefully removed from the seeding wells and placed in a 6-well plate 
which will be used for culturing. Special care was used when removing the modular scaffolds to 
avoid separating the two halves.  
4.8 Tissue Culture Protocol 
 Seeded scaffolds were covered in media and which was replaced when the color began to 
change. Based on the results of the reduced serum and collagen gel experiments two media 
protocols were used to test the final scaffold. Signs of early differentiation in the collagen 
hydrogel allowed for the reduction in the total culture time for the normal protocol. This protocol 
included 7 days with the ascorbic enhanced media and a following 15 days in media with 
ascorbic and insulin. A separate modified serum level protocol was used over the course of 15 
days to test the effects of this on cells cells grown in a 3D culture within a scaffold. The image 
below shows seeded scaffolds covered in media.  
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FIGURE 9: SEEDED SCAFFOLDS COVERED IN MEDIA 
4.9 Modular Scaffold Protocol 
 The benefit of seeding modular scaffolds was the ability to section the two scaffold 
halves and examine the cells on the inner face. This inner face between the two scaffolds is at a 
depth of 3mm from the surface of the tissue engineered construct. Based on the results of the 
ascorbic enhanced differentiation protocol in a 2D culture system as well as the 3D collagen 
hydrogel, the ATDC5 cell line doesn’t create large deposits of proteoglycans into the 
extracellular matrix until the cells have fully differentiated into chondrocytes. Knowing the 
timeframe within the phenomenon occurs and with the ability to stain and examine cells on the 
inner surface of the scaffold it is possible to test the viability of cells at a depth of 3mm based on 
the presence of these proteoglycan deposits.  
4.10 Histology Methodology and Testing 
 Once the cells were cultured in the scaffolds, they were visualized via histological 
processing and staining. The general procedure for histology involves fixing and processing a 
sample of soft tissue, embedding it into a block of paraffin wax, cutting 5-10um width slices 
using a microtome, mounting those slices on glass slides, and then staining the slices. However, 
due to the large mechanical and chemical differences between the plastic in the team’s scaffolds 
compared to a typical soft tissue, this procedure had to be altered in order to successfully section 
and visualize the cell-laden scaffold (Finalized Procedure in Appendix E). The major issues that 
had to be addressed were the toughness of the scaffold and adhering the scaffold to slides. 
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4.10.1 Scaffold Toughness 
 The experimental scaffolds are essentially 3 components: the plastic Poly-Lactic Acid 
(PLA), the Collagen Hydrogel, and the ATDC5 cells. While collagen is one of the harder soft-
tissues, it can be sectioned using a typical microtome. However, PLA is much harder, and in 
trials with untreated PLA scaffolds, the microtome was unable to cut sections at all. Instead the 
PLA was deformed and compressed into the surrounding wax block. In an attempt to soften the 
plastic, scaffolds were soaked in glacial acetic acid, acetone, or HCL either pre- or post-
processing and wax embedment. While no pre-processing had an effect on the plastic’s 
toughness, post-processing soaking in acetone for 2-5 minutes was able to soften several layers 
of plastic. The team was able to keep the scaffold soft enough to generate 5-6 micron sections by 
periodically soaking the scaffolds in acetone during microtome sectioning (soaked after every 
100-150 microns of scaffold depth cut using the microtome). 
4.10.2 Scaffold Adherence to Scaffold 
 PLA is a by nature a hydrophobic biodegradable plastic that undergoes hydrolytic 
breakdown. During initial histological staining of the PLA sections, no samples successfully 
remained on the test slides throughout the process. Initially, the team believed that this was due 
to disintegration of the scaffold, since many histological staining procedures, specifically H&E, 
involve caustic chemicals such as Xylene and glacial acetic acid; without the surrounding 
scaffold, the hydrogel seeded gel sloughed off the slides as well. 
The team conducted a number of experiments to eliminate the dissolution of PLA. The 
hematoxylin and eosin solutions used in H&E staining contain a large amount of glacial acetic 
acid (upwards of 30% in hematoxylin). The team experimented with varying dilutions of the 
staining solutions (up to 1:10), but scaffolds continued to degrade. Additionally, two water-based 
stains were used instead, Lite Green and Nuclear Fast Red (NFR). These stains do not 
incorporate the strong acids required for H&E staining, which makes them a much more viable 
option for the team’s PLA scaffolds. While scaffolds disappeared during this staining protocol, 
as well, the team noticed an interesting event. During a simple water wash in the NFR procedure, 
the team observed that entire scaffolds were lifting off of the test slide surface and being lost 
Project Number DGF – 111C 
during chemical washes. This event was confirmed to also occur in H&E staining, which implies 
that, rather than dissolving, the scaffolds were dissociating from the test slides  
 
FIGURE 10: PHOTO OF SCAFFOLDS DISSOCIATED FROM SLIDES IN WATER 
Several different experiments were run to better adhere the sections to test slides. 
Scaffolds were embedded in agar blocks in an attempt to stabilize the PLA on the slide and to 
hold the cell hydrogel in place. However, the PLA detached from the agar during the staining 
procedure. Sections were also mounted onto Poly-L-Lysine (PLL) slides or uncharged glass 
slides rather than the typical positively-charged test slides, but this also had no effect. Lastly, the 
team tried using an epoxy to physically adhere scaffolds to the slides. Two glues were used: 
Loctite(R) GO2 Glue and Liquid Nails(R) Perfect Glue™. Both glues successfully bonded 
scaffolds to all 3 slide types; however, only the Loctite(R) GO2 glue on the positively-charged 
slides was able to survive the Xylene washes used in the staining process. This process allowed 
the team to continue with histological staining of the scaffold. 
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FIGURE 11: RESULTS OF GLUE TESTS ON EMPTY SCAFFOLDS. LEFT-RIGHT: H&E STAIN WITH LOCTITE, H&E STAIN WITH 
LIQUID NAILS, NFR STAIN WITH LIQUID NAILS, NFR STAIN WITH LOCTITE 
4.10.3 Scaffold Staining  
Visualization of cells in the scaffolds was achieved with several different chemical stains. 
A modified procedure for Hematoxylin and eosin staining (H&E) was developed for initial 
visualization of cells from different seeding protocols at varying depths in the scaffolds (Staining 
Protocol in Appendix F). Additionally, several scaffolds slices from the Original and Modified 
protocols were stained for actin filament using a Phalloidin/DAPI protocol. 
5. Design Verification 
5.1 Cell Feasibility 
 Before moving on to seed the final design with cells it is important to analyse the results 
of experiments testing the feasibility of the ATDC5 differentiation and culture system. Results 
and insights gained from these experiments not only confirm the ability to use this cell type to 
test the scaffold, but allowed for planning the 3D cell culture and seeding methodology.  
5.1.1 BrdU Results 
 The results of the BrdU assay can be seen below. Hoechst staining results in a blue color 
for all cells, and cells with BrdU incorporated into the DNA appear with green nuclei. Cells were 
given BrdU for 24 hours before being fixed and plates were fixed on days 0, 7, 14, and 21. 
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Comparing numbers of cells which incorporated the BrdU to the total number of cells it was 
determined that only half of the cells stopped dividing by the end of the experiment. This result 
needs to be addressed moving forward with this project and taken into account with the 3D cell 
culture.  
Day of experiment Cell nuclei (40x) Dividing cells (40x) 
Day 0 
  
Day 7 
  
Day 14 
  
Project Number DGF – 111C 
Day 21 
  
FIGURE 12: RESULTS OF BRDU ASSAY WITH 25µM SCALE BARS 
5.1.2 Alcian Blue Staining 
 The results of the Alcian blue staining on ATDC5 cells throughout the differentiation 
process can be seen below. Early on in the differentiation of this cell type changes in 
morphology can be noted but no proteoglycans are deposited. The cells only stain positive with 
alcian blue later on in the process approaching day 28 of culture.  
  
 
Day 7 without ascorbic acid (20x) 
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Day 7 with ascorbic acid (40x) 
 
Day 14, or 7 days with insulin (40x) 
 
Day 21, or 14 days with insulin (40x) 
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Day 28, or 21 days with insulin (10x) 
FIGURE 13: RESULTS OF ASCORBIC ACID ENHANCED DIFFERENTIATION PROCEDURE 
5.1.3 Modified Serum Level Results 
Below are images of cells grown on tissue culture plastic with the standard and modified 
serum protocols. All plates from day 15 to 30 stained positive for deposits of proteoglycans and 
appeared similar to the original validation of this protocol, but large deposits of proteoglycans 
first appeared in the modified serum group. This modified protocol group also showed faster 
changes in morphology and the cells were more granular in appearance.  
  
Standard serum protocol (20x) Modified serum protocol (20x)  
  
Day 15 
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Day 18 
  
Day 21 
  
Day 24 
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Day 27 
  
Day 30 
FIGURE 14: RESULTS OF MODIFIED SERUM LEVEL ON ATDC5 DIFFERENTIATION 
5.1.4 Cellular Distribution Results 
The results of the cellular distribution experiment can be seen below. Solutions at each 
time point shown in the figure formed a solid gel, so damage to the cross links in the hydrogel 
appeared to be minimal. The low focal plane was determined using the 0 minute group at the 
level where cells could first be seen while moving from the bottom of the plate through the gel. 
Images of all wells were taken at this same focal plane and cells could still be seen in the 30 
minute wells. The high focal plane was determined using the 30 minute wells by moving the 
focal plane down through the gel. All time points were imaged and compared at this upper focal 
plane. Less cells were in focus in the 20, 10, and 0 minute wells, confirming a wider distribution 
of cells in the 30 minute wells. Given this wider distribution and the fact that it still made an 
intact hydrogel, scaffolds were seeded with cells in a gel allowed to remain at 25 degrees Celsius 
for 30 minutes.  
Project Number DGF – 111C 
 0 minutes 10 minutes 20 minutes 30 minutes 
High focal 
plane (20x) 
    
Low focal 
plane (20x) 
    
FIGURE 15: RESULTS OF CELLULAR DISTRIBUTION EXPERIMENT WITH 25µM SCALE BARS 
5.1.5 ATDC5 Differentiation in Collagen Hydrogel Results 
 The results of the ATDC5 differentiation in the collagen hydrogel can be seen below. 
Cells were fixed and stained on days 15, 18, 21, 24, 27, and 30. Both groups of cells, those 
grown in the hydrogel and on tissue culture plastic, displayed patches of deposited proteoglycans 
when stained with Alcian blue. These deposits of proteoglycans indicate differentiation into 
chondrocytes. This is the final indication of chondrogenesis. These patches grew in size and 
number from day 15 to 30 along with an increase in how granular the cells appeared. Cells 
grown in the hydrogel showed larger deposits of proteoglycans which appeared earlier over the 
course of the experiment.  
Collagen hydrogel (20x) Tissue culture plastic (20x)  
  
Day 15 
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Day 18 
  
Day 21 
  
Day 24 
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Day 27 
  
Day 30 
FIGURE 16: RESULTS OF ATDC5 DIFFERENTIATION WITHIN COLLAGEN HYDROGEL 
5.2 PLA Degradation Results 
TABLE 8: DEGRADATION RESULTS 
Time in solution (days) 1 7 14 21 28 
Initial Weight (g) 0.340 0.343 0.345 0.346 0.338 
Final Weight (g) .343 .346 .347 .348 .339 
 
 The PLA filament compatible with the MakerBot® 3D printer has a slow degradation 
rate compared to that of the compatible PVA filament.  Five whole scaffolds were printed in 
PLA and placed in distilled water at 37°C for a range of days, ranging from 1 day in water to 28 
days, and were then dried, weighed, examined, and compared under a microscope. The weights 
of the samples were all within one-tenth of a gram of one another and did not show the change in 
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weight we were expecting. This is most likely because the five individual prints were not 
identical in weight to one another and the polymer degradation is negligible compared to the 
printing precision. The defects caused by printing also made it difficult to tell how each scaffold 
varied from one to the other. PLA also undergoes bulk degradation rather than surface 
degradation so the edges are not the first place degradation is necessarily visible. Given the 
accuracy of the scale used, quantifiable results were not able to be obtained for the degradation 
of the MakerBot® PLA over the timeframe of the ATDC5 differentiation.  
5.3 Histology Results 
The results of the H&E and the Phalloidin/DAPI staining are shown below in Figures 18 
and 19, respectively. For the H&E staining, representative images were obtained for both single 
and modular scaffolds for the Original or Modified culture protocol. The modular scaffolds were 
split into their base pieces and processed separately. The scaffolds with the large central pore on 
each side are labeled “Middle” and the scaffolds with the smaller pores on each side are labeled 
“Outer.” Each image is from a slice that is from the outer (0-1.5 mm), middle (1.5-3.0 mm), or 
inner (3.0-4.5 mm) section of the scaffold. 
 
 Outer (0-1.5mm) Middle (1.5-3.0mm) Inner (3.0-4.5mm) 
Modified 
Protocol 
Middle 
(A) 
   
Modified 
Protocol 
Outer (B) 
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Modified 
Protocol 
Single 
   
Original 
Protocol 
Middle 
(A) 
   
Original 
Protocol 
Outer (B) 
   
Original 
Protocol 
Single 
   
FIGURE 17: H&E STAINING OF 5UM SCAFFOLD SLICES AT DIFFERENT DEPTHS 
Sections are all at 10x magnification with the exception of the Original Protocol Middle Scaffold 
Outer and Middle sections, and the Original Protocol Outer Scaffold Inner section. 
 
For the Phalloidin/DAPI fluorescent staining, sections from a Modified Protocol Middle and 
Single scaffold were stained.  
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 Phalloidin DAPI Phase Contrast 
Modified 
Protocol 
Middle 
(20X) 
   
Modified 
Protocol 
Single 
(20X) 
   
FIGURE 18: PHALLOIDIN/DAPI STAINING OF SCAFFOLDS. LEFT-RIGHT: PHALLOIDIN STAIN, DAPI STAIN, PHASE 
CONTRAST IMAGE 
5.4 Modular Scaffold Results 
 Staining the inner face of the modular scaffolds revealed proteoglycan deposits in the 
modified group at day 15 and the normal group at day 22, confirming the ability for the fractal 
geometry to allow proper nutrient penetration. These stained deposits can be compared against a 
negative control where the entirety of the Alcian blue stain washes out. The significance of these 
proteoglycan deposits as a viability marker confirm the scaffold design can allow cells to 
proliferate and differentiate at a depth of 3mm. 
 
Chondrogenesis at day 15 in modified protocol 
(4x) 
Chondrogenesis at day 22 in original protocol 
(4x) 
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Negative control (4x)  Negative control (4x) 
  
FIGURE 19: SECTIONED AND STAINED MODULAR SCAFFOLD COMPARED TO A NEGATIVE CONTROL 
Figure 19: Sectioned and stained modular scaffold compared to a negative control 
6. Discussion 
The data presented in Figure 17 shows cell staining at several scaffold depths for 
different scaffold designs and tissue culture protocols. Cells were present at all depths for each 
scaffold and protocol tested, though the Original Protocol Single scaffolds had very few cells. 
These results imply that the scaffolds were able to successfully support cells at depths up to 
3mm. Interestingly, the larger, modular scaffolds had a much greater amount of cells at greater 
depths than either single scaffolds, implying that the more complex geometry of the modular 
scaffolds had an effect in increasing cell proliferation. Additionally, the cells typically appear in 
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curving “sheets” several cell-lengths thick, which implies an organized structure. The 
Phalloidin/DAPI staining in Figure 18 agrees with this interpretation, as it shows that the 
cellular actin, which serves as the cytoskeleton and gives cells their shape, was organized into 
sheets coaxial to the hydrogel-PLA barrier similar to that seen in the H&E staining. 
 While the cells appear too organized and proliferating in the scaffolds, the team noticed 
an interesting trend with regards to the localization of the cell sheets. In almost all samples, cells 
appeared to localize to the periphery of the hydrogel, closest to the PLA structures (this is 
apparent in figures 17 and 18). However, the team also noticed that large “folded planes” of cells 
were visible on test slides outside of the scaffold structures (examples shown in Appendix G). 
The team believes that these disembodied planes of cells were initially located within the 
scaffold, but were sheared off during microtome sectioning. Even with acetone treatment, the 
PLA scaffold is much stiffer than the cell-laden hydrogel, and the resulting heterogeneity of 
stress during sectioning could deform the hydrogel and move it out of plane. During each cut, the 
out-of-plane cells/hydrogel are transplanted from inside the scaffold to the surrounding 
hydrophilic paraffin wax, and are then immobilized once the section is glued to a test slide. 
The team also conducted Alcian Blue staining on whole scaffolds to look for 
proteoglycan deposits (shown in Figure 19). Proteoglycan deposits are a sign of chondrogenesis, 
so increased deposits implies that the cells survived long enough to differentiate (21-28 days). 
The adapted modified protocol used to seed and culture the scaffolds showed more 
chondrogenesis given the results of the Alcian blue staining. This is due in part to the seeding of 
prechondrocytes instead of untreated ATDC5 cells as well as the modified serum levels. The 
preliminary cell experiments showed these lowered serum levels result in faster differentiation 
and this was demonstrated again in the tissue engineered constructs. Higher levels of these 
proteoglycan deposits are present towards the surface of the scaffold. This is due to the slight 
degradation of the PLA over the course of culturing the tissue engineered construct. This resulted 
in an increase in nutrient perfusion, showing the effect the biomorphic scaffold had on the 
ATDC5 cells grown within it.  
6.2 Economics 
 The economics of this technology are within the means of many small labs and startup 
companies. Many of the labs and corporations haven’t explored using 3D printing to create cell 
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scaffolds due to the high costs of rapid prototyping machines. However, given that a low cost 
commodity 3D printer can be used to create biomorphic scaffolds like the ones in the project, the 
cost of entry has been significantly lowered for the ability to create cell scaffolds for this type of 
research.  
6.3 Environmental impact 
The environmental impact of this technology is fairly low overall. The material used for 
printing is fully biodegradable, and the manufacturing process used to create the scaffolds 
resulted in a minimal amount of this material that needed to be discarded. The tissue engineering 
and cell culture required to created tissue engineered constructs from these biomorphic scaffolds 
contributed more to the environmental impact of this technology than manufacturing the 
scaffolds. This is due to the large amount of sterile single use products that need to be used. This 
includes tissue culture plates, bottles, serological pipettes, and micropipette tips used to culture 
cells and tissue as well as seed the scaffolds. Scaling up this process and fairly simple and could 
result in lessening the environmental impact. Commodity 3D printers and available for low costs 
and further improvements could be made in the manufacturing process to lessen discarded 
material. Scaling up the tissue culture could involve automated processes, but a dedicated 
professional would still be required to seed scaffolds with cells.  
6.4 Societal influence 
This technology, if commercialized, would have a significant impact on society. This 
proof of concept could be further developed to revolutionize the way meniscal tears and 
avascular cartilage damage is treated. Not only could this method of scaffold creation be used to 
create a fractal inspired scaffold to grow a tissue engineered construct in the shape of the full 
meniscus, but a patient’s wound site could be imaged and a fractal inspired cell scaffold could be 
created that conforms specifically to this wound site. A scaffold could be implanted to prevent 
scarring while another in cultured with cells before replacing the preliminary scaffold, eventually 
fully replacing the patients damaged or missing tissue. However this project is only a proof of 
concept and further testing needs to be conducted. This could include growing larger tissue as 
well as implanting these tissue engineered constructs into living systems.  
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6.5 Political ramifications 
 The only political concerns of this technology would be the use of certain cell lines. The 
controversy of using embryonic stems cells could be avoided by using induced pluripotent stem 
cells produced from the patients’ native cells. If the politics of embryonic stem cells lines can be 
avoided, and given the low cost of manufacturing these scaffolds, this technology has the 
potential to improve global health care, including developing countries.  
6.6 Ethical concerns 
There are many ethical concerns given the implantation of living cells as a form of 
therapy. There is the potential of immortalized cell lines to continue proliferating and forming 
cancer in a patient’s body. Furthermore, implanting living cells into the body of patients could 
lead to an infection caused by an undiscovered virus or other form of contamination in the 
manufacturing and tissue engineering processes.  
6.7 Health and safety issues 
There are no immediate health and safety issues in terms of this preliminary research. If 
this technology if further pursued and scaled up for use commercially, FDA and ISO standards 
will need to be met and adhered to. Potentially issues which will need to be explored include 
how the laboratory differentiated cells will incorporate into the native tissue and how the native 
cells will interact with the scaffold. The healing time of implantation procedures will need to be 
taken into consideration as well as avoiding scar formation around the tissue engineered 
construct. Finally, interactions with the implanted PLA and the native tissue will need to be 
explored and addressed as necessary.  
6.8 Manufacturability  
The manufacturability of these scaffolds is fairly straight forward. They can be created 
with an unmodified commodity 3D printer, but simple modifications could be made to increase 
resolution and improve the surface area to volume ration. The manufacturing process could be 
scaled up given the relatively cheap cost of these printers. The tissue engineering and cell culture 
can be scaled up as well with the inclusion of automated processed, but there still needs to be a 
dedicated professional to seed the scaffolds with cells.  
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6.9 Sustainability 
This technology and manufacturing process have a low economic and environmental 
impact, leading to this process being highly sustainable. Overall this manufacturing process 
required a small amount of financial capital to begin and used limited material resources. The 
most expensive aspect of this research includes the cost of sterile single use lab equipment and 
culturing media used for growing cells and seeding scaffolds. Overall, this process is sustainable 
for small research labs as well as startup companies to continue given the results and clinical 
significance.  
7 Final Design 
 The final scaffold design used for this project was a second level recursion cylindrical 
Menger Sponge. For ease of processing and cellular visualization the scaffold was broken into 
three modular sections; an identical top and bottom section and a middle section. Each of these 
scaffold sections were 9mm x 9mm x 3mm while the second level of pores had a diameter of 
1mm and the central pores had a diameter of 3mm. The central pores located on the side of the 
middle section of scaffold had a diameter 2.5 mm. The second level of recursion of the final 
design allowed for nutrient penetration to the core of the scaffold and the reduction of cell 
necrosis. This design was also less computationally demanding and could be processed with the 
resources available to the group.  
 
 
FIGURE 20: CAD MODEL OF MODULAR SCAFFOLD SECTIONS OF 2ND LEVEL RECURSION CYLINDRICAL MENGER SPONGE - 
CROSS SECTIONED VIEW 
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FIGURE 21: 3D PRINTED PLA MODULAR SCAFFOLD SECTIONS OF SECOND LEVEL RECURSION CYLINDRICAL MENGER 
SPONGE (LEFT TO RIGHT: TOP DOWN VIEW, STACKED SIDE VIEW) 
A current limitation of thick tissue culture is the necrosis of cells within the center of the 
culture over time. Typical thick tissue engineering deals with tissue growth by the plating of cells 
in a two dimensional culture. These cells are cultured in complete media and allowed to grow. 
As the cells continue to grow in the culture plates they begin grow atop one another and this 
prevents nutrients from reaching the cells at the bottom of the tissue, leading to cell necrosis. 
This cell necrosis can occur in tissue deeper than 1mm (Rajagopalan & Robb 2006) and is a 
great limitation for current thick tissue culture 
Biodegradable scaffolds show promise in preventing cell necrosis by allowing increased 
nutrient penetration of the thick tissue culture due to the 3D structure of the scaffold. As the 
scaffold degrades as the cells begin to grow and proliferate this allows nutrients to penetrate into 
the core of the scaffold and reach the cells within, reducing cell necrosis throughout the scaffold. 
Our design focused on the use of fractals, such as a Menger Sponge fractal, to increase the 
surface area to volume ratio of our biodegradable scaffold. An increased surface area allows for 
greater cell proliferation and an increased degradation rate of the scaffold, as well as an increased 
volume of nutrients that can be delivered to the cells.  
Our scaffold design allowed cells to survive long enough to differentiate into thick tissue. 
This was visualized via cellular expression of proteoglycans. The edges and surfaces of the 
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scaffold seemed to improve localized cell proliferation while cells were seen to conform to the 
curves of the scaffold. This conformation was seen by the presence of actin filaments, a major 
cytoskeletal component, during histology testing. The visualization of proteoglycans and the 
conformation and localization of cells to the surfaces and curves of the scaffold implies that there 
was nutrient flow due to the degradation of the scaffold. This increased nutrient flow showcases 
the advantages of using a three dimensional, biodegradable scaffold for thick tissue engineering 
and the reduction of overall cell necrosis. 
While our scaffold design showed improved nutrient penetration to the cells within the 
scaffold there are some limitations to the scaffold design. Our final scaffold design was a second 
level recursion cylindrical Menger Sponge that was broken into three modular sections for ease 
of processing and cell visualization. This second level of recursion of the fractal allowed for an 
adequate surface area to volume ratio but an increased level of recursion in the scaffold, such as 
a third or fourth level of recursion, would allow for an increased ratio and therefore an increase 
in nutrient flow. Our ability to generate an increase in the recursion level of our scaffold design 
is limited to computational overhead that the group has access to.   
 All scaffolds were printed using a MakerBot® Replicator 2, where the print settings had 
been modified to increase the resolution of the scaffold. Without modifying the hardware of the 
printer the group was able to print large quantities of the scaffold. The Replicator 2 is a 
commercially available printer that costs two thousand dollars, a large decrease in price 
compared to other industrial printers that can easily cost upwards of ten thousand dollars. The 
PLA used to print the scaffolds came in the form of a 1kg spool and cost eighty dollars. Based 
off the amount of scaffold sections the group was able to print using a 1kg spool of PLA a single 
printer could print hundreds of scaffold sections at a pennies per scaffold section. Manufacturing 
these scaffolds on a large scale can be economically feasible if this project was to develop.    
 The success of this scaffold design shows that our scaffold device is a novel method to 
culture thick tissue. This project also has shown that 3D printing allows for the creation of 
complex geometries that can be used to increase the surface area to volume ratio, something that 
is shown to be vital for nutrient penetration and delivery to cells in thick tissue culture. That 
these scaffolds were created on a commercially available printer shows that it is possible to print 
these complex geometries on most any type of commercially available printer. These printers can 
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potentially be modified to increase the resolution of any future printed scaffolds and as 
commercially available printers are much cheaper to purchase that industrial 3D printers, this 
makes these printers ideal for use in any further research into thick tissue engineering.  
8 - Conclusions and Recommendations 
This project focused on engineering cartilaginous tissue in 3D printed PLA scaffolds. The 
following section outlines the conclusions drawn from our results, recommendations for future 
improvements, and the impact on the thick tissue engineering. 
8.1 - Objectives 
The main objective of this project is developing a novel method for thick tissue culture 
that creates a viable environment for cell proliferation and differentiation into cartilaginous tissue 
using a biodegradable scaffold that is printed using a commodity 3D printer. The results derived 
from this project show the objective has been met: the scaffolds’ design influenced the cell’s 
behavior. The following highlights some of the ways in which the project’s objectives were met. 
The scaffold itself was created to provide a high surface area to volume ratio in order to 
provide nutrients to the center of the thick tissue, which was hypothesized to prevent necrosis. In 
order to test the viability of cells in the center of the scaffold, the modular scaffold design was 
created so cells that were located in the thick part of the scaffold could be analyzed. Imaging and 
staining cells within the modular thick scaffolds show the cells’ structure mimic that of cartilage 
and also proves the viability of the cells as the amount of proteoglycans present in the scaffolds 
increased over time, proving presence of cartilaginous tissue and that the cells were viable up to 
21 days when these secretions are produced. The location and geometry of cells and cytoskeleton 
with relation to the scaffold walls showed the scaffolds influence over the cells. For example, the 
density of proteoglycan deposits near the walls of the scaffold pores relative to the density of the 
inner portion of the pores was much greater. Images of the cells also showed alignment along the 
scaffold walls. 
8.2 - Future Improvements 
While this project achieved its overarching objective, there are many avenues for 
improvement due to the limited time constraints and available resources. Some areas for future 
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improvement include providing greater computing power, better printer resolution, and creating 
a customizable polymer as well as engineering whole cartilaginous tissues.  
Fractal CAD models, both open source and custom made, often require a lot of 
computing power to manipulate because of their high level of detail. This intricate detail made 
the CAD software available throughout our project run very slowly and often crash. Access to 
greater computing power would allow greater fractal recursion levels, the creation of more 
complex gross geometries, such as a meniscus, out of the modular scaffold “building blocks,” 
and making a more intricate way of connecting the modular blocks together, which were both 
limited due to insufficient computing power.   
Manufacturing the scaffolds using the Replicator2 3D printer with the default settings 
does not allow for a high enough resolution to print the small details of the scaffolds. The 
resolution can be slightly modified two ways: the ReplicatorG software itself can changed since 
it is an open source program or the printer hardware can be modified. The ReplicatorG software 
allows the user to modify the feeds and speeds of the extruder as well as the level of the build 
plate while the physical nozzles of the printers can be changed for ones with different diameters. 
Even with these possible modifications to improve printer resolution, the fractals with higher 
recursion levels could not be printed. 
PLA, the biodegradable polymer that is used in these scaffolds, is the commercially 
available filament sold from the MakerBot®. Different grades of PLA will have different 
degradation rates depending on the molecular weights of the filament. A custom polymer having 
a molecular weight that allows it to degrade at a rate close to that of the rate of cell proliferation 
would cause better nutrient flow throughout the scaffold. The two biodegradable polymers that 
have filaments compatible with 3D printing, PLA and PVA both experience bulk degradation. 
Bulk degradation occurs uniformly throughout the entire scaffold. Surface degradation, where 
the scaffold degrades first from the edges and pores of the scaffold, would also allow for better 
nutrient flow.  
The next step in further developing this project is to begin creating differing gross 
geometries; for example, the knee meniscus, out of the smaller “building block” scaffolds 
developed in this project. Since some of the cartilaginous tissue in the body is thicker than that 
which we experimented with, viability testing would be necessary to make sure there is not a 
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necrotic core. Mechanical testing of the tissue would also be necessary as the scaffold degrades 
to ensure the engineered tissue is mechanically similar to the natural tissue. Further testing and 
clinical trials would also have to be done using human cells, either allogeneic or autologous 
chondrocytes, prior to clinical use. 
8.3 - Clinical Importance 
 This method for engineering thick tissues has the potential to make an impact on the 
industry standard because of the accessibility of the technology and resources necessary to 
replicate this work in a clinical setting. Hypothetically, if the steps in the Previous Works section 
above, as well as clinical trials were carried out and proven successful, providing more effective 
surgery for cartilage damage, such as the meniscus, would be possible. A doctor could take an 
MRI image of a damaged tissue and have a scaffold replicated and 3D printed in the gross 
structure of a patient’s tissue. The PLA scaffold would have an internal configuration of different 
scaled Menger Sponge scaffold blocks, which, when seeded with either allogeneic or autologous 
chondrocytes and grown into the tissue, would provide mechanical properties similar to a healthy 
tissue. The technology discussed in this paper is still far from being used in a clinical setting, as 
discussed in the Previous Works section above, but the potential for clinical improvement is 
great. 
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Appendices: 
Appendix A: Cell Passaging 
 
1.) Aspirate media and wash cells two times with DPBS(-). 
 
2.) Trypsinize cells for 10 minutes to digest the extracellular matrix and lift them off the plate.  
 
3.) Add fresh media to stop the trypsin. 
 
4.) Aspirate cell suspension and centrifuge for 5-10 minutes.  
 
5.) Resuspend pelleted cells in fresh media and count or split as desired.  
 
6.) Pipette desired amount of cells onto new plate filled with media and transfer to the incubator.  
 
 
Appendix B: Alcian blue staining protocol 
 
1.) Wash sample in 3% acetic acid, 10 minutes for each rinse.  
 
2.) Incubate sample with Alcian blue stain for 15 minutes at 37° C, or 30 minutes at room 
temperature.  
 
3.) Wash sample in 3% acetic acid, 10 minutes for each rinse. 
 
4.) Wash sample in sterile water, 10 minutes for each rinse. 
 
5.) Store stained samples in sterile water. 
 
 
Appendix C: Scaffold seeding protocol 
 
1.) Soak printed scaffolds and seeding wells in 70% isopropyl alcohol for a minimum of 2 hours. 
 
2.) Use sterile forceps to remove scaffolds and seeding wells from isopropyl alcohol and place in 
a sterile tissue culture plate in the biosafety hood. Keep plates uncovered with the UV 
light on to allow the isopropyl alcohol to evaporate and complete the sterilization process. 
 
3.) Use sterile forceps to place the scaffolds into their respective seeding wells, either the single 
or modular wells.  
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4.) Store PureCol EZ Gel in ice under the hood. 
 
5.) Trypsinize cells, count, and perform serial dilutions until the desired cell concentration is 
reached. 
 
6.) Pipette desired number of cells in less than 200µl of media into PureCol EZ Gel and mix 
thoroughly. 
 
7.) Store PureCol EZ Gel at 25° C for 30 minutes. 
 
8.) Pipette 245µl of cell hydrogel solution onto the single scaffolds and 650µl onto the modular 
scaffolds.  
 
9.) Cover tissue culture plate and move to incubator for 90 minutes.  
 
10.) Move tissue culture plate back to biosafety hood and remove scaffolds from seeding wells 
using sterile forceps. Care needs to be taken when removing the modular scaffolds 
without separating the two scaffold halves.  
 
11.) Cover scaffolds with respective media and culture using standard methods. 
 
 
Appendix D: Modular Scaffold Separation 
 
1.) Using sterile forceps and a tissue culture plate, place modular scaffolds on their side and grip 
one of the scaffold halves with the sterile forceps. 
 
2.) Using a sterile scalpel, carefully cut through the hydrogel connecting the two scaffold halves. 
Attempt using one clean cut to have a smooth surface on the inner face of the individual 
scaffold halves. 
 
3.) While this cut is being performed carefully observe and keep track of which side of the 
scaffold halves is the inner face. Once separated place the inner face down onto the tissue 
culture plastic.  
 
4.) Inner cells at a depth of 3mm can now be observed and stained for analysis.  
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Appendix E: Histological Tissue Processing and Microtome Sectioning 
 
1.) Put scaffold in a processing cassette and store in Isopropyl Alcohol. If scaffold is modular, 
cut it into two pieces by following steps 1-2 of Appendix D. 
 
2.) Process the Cassettes using a Tissue Processor under standard tissue processing conditions. 
 
3.) Embed processed scaffolds in a paraffin wax. 
 
4.) Use a Microtome to slice away wax until the surface of the scaffold is exposed. 
 
5.) Soak the wax-embedded scaffold in acetone for 2-3 minutes to soften the PLA enough that 5-
6 um slices can be cut using the microtome. 
 
6.) Prior to sectioning the scaffold with the microtome, prepare several positively-charged test 
slides by labeling them and spreading a thin layer of Loctite(R) GO2 glue over the slide surface. 
 
7.) Use the Microtome to generate 5-6 um sections from the acetone soaked scaffold. Carefully 
place sections directly on the glue-covered slide after cutting them (do not float samples on water 
as is typical for histology). 
 
8.) Repeats steps 5-7 as necessary when the scaffold becomes too difficult to section or until 
sections of the desired scaffold depth have been generated. 
 
 
Appendix F: Hematoxylin and Eosin Staining Protocol 
This process was adapted from the Gateway Park Core Labs procedure provided by Hans B. 
Snyder. Each step is done in a separate reagent bath. 
 
1.) De-paraffinize slides in xylene (1) for 2 minutes (re-use) 
 
2.) De-paraffinize slides in xylene (2) for 2 minutes (re-use) 
 
3.) Clear slides in 100% ethanol for 2 minutes 
 
4.) Clear slides in 100% ethanol for 2 minutes 
 
5.) Hydrate slides in 95% ethanol for 2 minutes 
 
6.) Hydrate slides in running DI water for 5 minutes 
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7.) Stain slides in Harris Hematoxylin for 5 minutes (re-use) 
 
8.) Wash slides in running DI water for 5 minutes 
 
9.) Stain in Eosin for 1 minute (re-use) 
 
10.) Dehydrate in 95% ethanol for 1 minute 
 
11.) Dehydrate in 100% ethanol for 1 minute 
 
12.) Dehydrate in 100% ethanol for 1 minute 
 
13.) Dehydrate in 100% ethanol for 5 minute 
 
14.) Clear in xylene (4) for 2 minutes (re-use). 
 
15.) Clear in xylene (5) for 1-5 minutes (re-use). During this step, observe the test slides. If the 
glue on the slide begins to bubble/deform, immediately remove slides from xylene and seal using 
a coverslip and copious slide glue. Otherwise, coverslip the slides after the xylene wash is 
finished. 
 
16.) Wait for the glue to dry and image using a light microscope. 
 
Solutions: 
 
Stock Eosin Solution: 1.0g Eosin Y, 100.0mL DI H2O 
Stock Phloxine: 1.0g Phloxine B, 100.0mL DI H2O 
Working Eosin Solution: 100.0mL Stock Eosin, 10.0mL Stock Phloxine, 280.0mL 95% Ethanol, 
4.0mL Glacial Acetic Acid 
Harris Hematoxylin Solution: Store bought; filter before each use. 
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Appendix G: Cell Folding Images 
 
 
Figure H.1: 10x image of cell folding from an H&E stained Original Protocol Outer 
Scaffold Slice 
